- Home
- PRPL vs ZTEK Comparison
PRPL vs ZTEK Comparison
Compare PRPL & ZTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRPL
- ZTEK
- Stock Information
- Founded
- PRPL 2010
- ZTEK 2008
- Country
- PRPL United States
- ZTEK Canada
- Employees
- PRPL N/A
- ZTEK N/A
- Industry
- PRPL Home Furnishings
- ZTEK Major Chemicals
- Sector
- PRPL Consumer Discretionary
- ZTEK Industrials
- Exchange
- PRPL Nasdaq
- ZTEK Nasdaq
- Market Cap
- PRPL 96.8M
- ZTEK 103.3M
- IPO Year
- PRPL N/A
- ZTEK N/A
- Fundamental
- Price
- PRPL $0.79
- ZTEK $1.60
- Analyst Decision
- PRPL Hold
- ZTEK
- Analyst Count
- PRPL 2
- ZTEK 0
- Target Price
- PRPL $1.25
- ZTEK N/A
- AVG Volume (30 Days)
- PRPL 1.0M
- ZTEK 82.9K
- Earning Date
- PRPL 05-06-2025
- ZTEK 06-26-2025
- Dividend Yield
- PRPL N/A
- ZTEK N/A
- EPS Growth
- PRPL N/A
- ZTEK N/A
- EPS
- PRPL N/A
- ZTEK N/A
- Revenue
- PRPL $472,015,000.00
- ZTEK $44,936.00
- Revenue This Year
- PRPL N/A
- ZTEK N/A
- Revenue Next Year
- PRPL $5.62
- ZTEK N/A
- P/E Ratio
- PRPL N/A
- ZTEK N/A
- Revenue Growth
- PRPL N/A
- ZTEK 92.38
- 52 Week Low
- PRPL $0.56
- ZTEK $0.50
- 52 Week High
- PRPL $1.59
- ZTEK $1.31
- Technical
- Relative Strength Index (RSI)
- PRPL 59.52
- ZTEK 60.34
- Support Level
- PRPL $0.76
- ZTEK $1.51
- Resistance Level
- PRPL $0.97
- ZTEK $1.83
- Average True Range (ATR)
- PRPL 0.07
- ZTEK 0.18
- MACD
- PRPL 0.03
- ZTEK 0.01
- Stochastic Oscillator
- PRPL 53.74
- ZTEK 68.99
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.
About ZTEK Zentek Ltd.
Zentek Ltd is an IP development and commercialization company focused on next-gen healthcare solutions in the areas of prevention, detection, and treatment. It is focused on commercializing ZENGuard, a patent-pending coating with 99% antimicrobial activity, including against COVID-19, and the potential to use similar compounds as pharmaceutical products against infectious diseases.